Physician profile
Melissa Mary Hamilton
NPI 1831720168
$23,134.95
in general payments reported to CMS, 2019-2025
14 companies · $19K in 2025
The $19K reported for 2025 was more than what 99% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $289 · 2022: $1,578 · 2023: $424 · 2024: $1,827 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Travel and Lodging: $6,083 · Food and Beverage: $2,885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,300.00 |
| Travel and Lodging | $6,082.50 |
| Food and Beverage | $2,885.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $19,733.75 | 2021-2025 | Barostim Neo System |
| Abbott Laboratories | $1,935.51 | 2022-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $687.13 | 2021-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $220.73 | 2025 | Assure Wcd |
| Amgen INC. | $125.00 | 2024 | |
| Abiomed | $84.22 | 2023 | Impella |
| Alnylam Pharmaceuticals INC. | $77.58 | 2025 | Onpattro |
| Scpharmaceuticals INC. | $69.40 | 2025 | |
| Merck Sharp & Dohme LLC | $58.04 | 2022 | |
| Novartis Pharmaceuticals Corporation | $44.94 | 2025 | |
| Medtronic, INC. | $30.17 | 2025 | |
| Getinge USA Sales, LLC | $30.10 | 2024 | Acrobat-I Stabilizer |
| Pfizer INC. | $22.41 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $15.97 | 2025 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Hamilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.